$3.09
2.66% today
Nasdaq, Feb 05, 07:44 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock News

Neutral
GlobeNewsWire
about 2 hours ago
SAN FRANCISCO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cardlytics, the advertising technology company that connects marketers with consumers through their banking apps, is facing a class-action lawsuit alleging that it misled investors about its growth prospects.
Neutral
Accesswire
about 2 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330...
Neutral
Accesswire
about 19 hours ago
CDLX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2025 / Cardlytics, the advertising technology company that connects marketers with consumers through their banking apps, is facing a class-action lawsuit alleging that it misled investors about its growth prospects. Hagens Berman urges Cardlytics, Inc. (NASDAQ:CDLX) investors who suffered...
Neutral
GlobeNewsWire
one day ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
2 days ago
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).
Neutral
GlobeNewsWire
2 days ago
SAN FRANCISCO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cardlytics, the advertising technology company that connects marketers with consumers through their banking apps, is facing a class-action lawsuit alleging that it misled investors about its growth prospects.
Neutral
PRNewsWire
2 days ago
NEW YORK , Feb. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Neutral
PRNewsWire
3 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options  If you purchased or acquired securities in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-933...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today